R.G.P. Gijtenbeek, MSc

No picture available
r.g.p.gijtenbeek umcg.nl


  1. Early treatment response may predict long-term mepolizumab benefit in severe asthma

    Kroes, J. A., Wiegman, M. I., Van der Meer, A-N., Gijtenbeek, R. G. P., De Jong, K., Zielhuis, S. W., Van Roon, E. N. & Ten Brinke, A., 28-Sep-2019, In : European Respiratory Journal. 54, Suppl. 63, 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status

    Gijtenbeek, R. G. P., de Jong, K., Venmans, B. J. W., van Vollenhoven, F. H. M., Brinke, A. T., Van der Wekken, A. J. & van Geffen, W. H., 12-Aug-2019, In : Cochrane Database of Systematic Reviews. 2019, 8, 14 p., CD013382.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (3) »

ID: 103602138